Group One Trading
OCRX

Group One Trading’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Group One Trading’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,154
Closed -$12K – 5185
2016
Q1 		$12K Sell
4,154
-1,346
-24% -$3.84K ﹤0.01% 3969
2015
Q4 		$17K Buy
+5,500
New +$18.8K ﹤0.01% 4001

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's OCRX Position: Q2 2016 in Review

Group One Trading sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2016, closing a stake of 4,154 shares — an estimated $12K sold.

Group One Trading first reported a position in OCRX in Q4 2015 and held it in 2 quarters. The position peaked at $17K in Q4 2015. 33 funds tracked by Wall St. Rank hold OCRX as of Q2 2016.

  • Group One Trading reported no remaining Ocera Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Group One Trading sold 4,154 Ocera Therapeutics, Inc. shares in Q2 2016, an estimated $12K.
  • Group One Trading first reported a position in Ocera Therapeutics, Inc. in Q4 2015 and held it in 2 quarters.
  • Group One Trading's Ocera Therapeutics, Inc. position peaked at $17K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2016.

Based on Group One Trading's 13F filing for Q2 2016, filed 12 Aug 2016.